Working at the Sanger Institute is truly unique. We put collaboration, innovation and support for people as individuals at the centre of everything we do. Join us to help shape the future by delivering life-changing science with the reach, scale, and creativity to solve some of humanity’s greatest challenges.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
We are committed to training the next generation of pioneering genome scientists and clinicians. At the Wellome Sanger Institute we give PhD students and postdocs all the tools they need to succeed in the field of genomics research.
Our vision and mission is to deliver world-leading genomics research in collaboration with research partners across the globe. Discover how our funding gives our leadership the independence to conduct bold, ambitious science that pioneers new fields in health, disease and conservation.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
By focusing on fundamental discovery research led by our faculty and employing our unique scale in cutting-edge data generation and analysis, we deliver discoveries not easily made elsewhere.
From providing fundamental resources for understanding biology to exploring cancer genomes and the effects of variation in human genomes, our work lays the foundations for personalised medicine. We also reveal the secrets of human development and how infectious diseases evolve and spread.
Discover how our leadership and structures are designed to enable holistic and effective decision making, with transparency and accountability woven into their make up.
The diversity in skills and knowledge that we all bring make our Institute the thriving ideas factory that it is. Discover how we support each other to reach our full potential and thrive. We celebrate diversity and seek to ensure that everyone has equal access to professional and career development opportunities.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
We play a pivotal role in helping to shape Government and International research policies. We also lead the way in developing guidance to support our scientists to carry out their research ethically, equitably and responsibly.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
We are sited on the Wellcome Genome Campus at the very heart of a global hub of fundamental and applied genomic research, education and engagement. It is home to some of the world’s foremost institutes and organisations using genomes and biodata to deliver science with the reach, scale and imagination to solve some of humanity’s greatest challenges and maximise societal benefit.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
Our research is organised into six primary Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. In addition, our Associate Research programmes pioneer new approaches to studying health and disease.
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
The Sanger Institute has published papers in some of the most prestigious scientific journals. We aim to publish research that will transform biology and improve healthcare.
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Sanger Institute’s Research Policies are designed to provide guidance to help researchers navigate the legislation relating to their research and to ensure that research is ethical and legal.
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
The Sanger Institute played a major role in the genomic surveillance of the COVID-19 pandemic, providing large-scale high-throughput sequencing of the SARS-CoV-2 virus and analysis of its evolution and spread in the UK.
Throughout the COVID-19 lockdown of 2020-2021 we hosted a series of monthly freely available and open virtual seminars. From using genomic approaches to map all cell types in the human body, understand how cancer develops, and track the evolution and spread of global diseases, our senior scientists and faculty presented the latest developments in their field.
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease or analytic focus. In all cases, the studies provide insights into human, pathogen, cellular evolution, the phenotypic and hence biological consequences of genome variation and the processes which cause mutations.
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is founded on the talents, imagination and curiosity of our people. Our wet-lab scientists, bioinformaticians, developers, engineers and skilled administrators work together to deliver cutting-edge research. Join us Read more
The Sanger Leadership Team is an Executive Committee that enables holistic and effective decision making, with transparency and accountability woven into its make up.
We draw on a number of experienced and internationally recognised scientists to provide independent scientific support, advice and challenge to help us maintain our scientific excellence.
Our science is founded on the talents, imagination and curiosity of our people. Our wet-lab scientists, bioinformaticians, developers, engineers and skilled administrators work together to deliver cutting-edge research. Join us Read more
Our Faculty conceive and deliver our science. Within our strategic framework the Institute’s scientific aspirations are driven by their vision, imagination and intellectual energy.
Our Associate Faculty combine their skills and knowledge with the Sanger Institute’s unique abilities to conduct data generation and analysis at scale to pioneer genomic research in new areas.
Almost 1,000 scientists, developers, engineers and skilled professionals work together to deliver the Sanger Institute’s cutting-edge genomic research.
Our science is founded on the talents, imagination and curiosity of our people. Our wet-lab scientists, bioinformaticians, developers, engineers and skilled administrators work together to deliver cutting-edge research. Join us Read more
From PhD students and Postdoctoral Fellows, bioinformaticians and laboratory managers, search for our staff who the support the delivery of pioneering science.
Almost 1,000 scientists, developers, engineers and skilled professionals work together to deliver the Sanger Institute’s cutting-edge genomic research.
Our science is founded on the talents, imagination and curiosity of our people. Our wet-lab scientists, bioinformaticians, developers, engineers and skilled administrators work together to deliver cutting-edge research. Join us Read more
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
Find out how our translation team maximises the socioeconomic impact of the Sanger Institute’s discoveries by translating our science into products, services and technologies that benefit patients in a variety of settings.
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
Read how we benefit society by buiding on the innovative capabilities of our people by engaging with businesses and creating commercial opportunities. We also develop a unique and vibrant ecosystem to establish and grow innovative genomics and biodata businesses.
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
Read examples of how we engage with funding, R&D, service and clinical communities to promote real-world utilisation of the Sanger Institute’s technologies and resources.
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
The Communications team promote the Sanger Institute’s research and discoveries, using both traditional media such as print, radio interviews and TV footage and social media like Twitter, Facebook and the Sanger Institute blog
Sir John Sulston awarded the 2002 Nobel Prize for Physiology or Medicine
Press Office7 Oct 2002
In 1992, Sulston was appointed the first Director of the Wellcome Trust Sanger Institute in Cambridgeshire which made the UK's contribution to the international Human Genome Project.
Professor Sir John Sulston, former director of the Wellcome Trust Sanger Institute
“It’s tremendously exciting for me because once again it reinforces the power of fundamental research. Our work on C. elegans at the Medical Research Council Laboratory of Molecular Biology emphasized the benefits of sharing large amounts of information. We took a global approach to discover the mechanisms that led to the development of the worm.
“The same is true for genomics. When results are shared freely amongst the biological community, as has been done for the worm and the Human Genome Projects, specialist scientists can move much more rapidly towards their goals. This flow of information, which builds in strength as it circulates, benefits medicine. Remember, this only the start and we need dedicated people to translate the fundamental knowledge into real healthcare benefits.
“This is founded in Sydney Brenner’s vision, in setting up the worm project — an entirely new system for developmental biology. My contribution to this was learning to watch the cells dividing, and sometimes dying, under the microscope. We could actually see programmed cell death in action, so beautiful, so clear and so reproducible. These qualities meant we could predict the moment of death, and begin the search for mutants to understand how this happened.
“That’s what Bob Horvitz did — starting at our lab in Cambridge and then powering away at the Massachusetts Institute of Technology, discovering what happens in these developmentally programmed cells. This was real fundamental work, but it showed that the genes involved have equivalents in humans that are involved in cancer, neurodegeneration and other diseases.
“The worm worked so well because the community held an ethos of sharing — just as the public genome projects have — from the beginning. We gave all our results to others as soon as we had them. From sharing, discovery is accelerated in the community. Research is hastened when people share results freely.”
Sir John Sulston Former Director of the Wellcome Trust Sanger Institute
“Sir John’s achievements rank alongside our greatest biological and medical discoveries. His C. elegans work inspired a new era in scientific research, and the sequencing of its genome was the spark that initiated the international Human Genome Project.
“These were among of the many highlights in the career of this outstanding scientist, who provided unswerving and principled leadership during his time as Director of the Wellcome Trust Sanger Institute.”
Dr Mike Dexter Director of the Wellcome Trust
“This is absolutely fantastic news! It’s great for John and for British Science. I am thrilled that John’s work has been honoured by the highest award. John has been instrumental in laying out several of the foundations upon which almost all experimental work in the worm depends. This began with the lineage map and extends to the genome sequence. John’s vision in developing and persevering to finish the job is an inspiration to us all.”
Dr Allan Bradley who replaced Sir John as Director of the Wellcome Trust Sanger Institute
More information
Professor Sir John Sulston, former director of the Wellcome Trust Sanger Institute
Further Information About Sir John Sulston
Sir John (60) graduated from Cambridge University in 1963. After completing his PhD on the chemical synthesis of DNA, he moved to the USA to study prebiotic chemistry (the origins of life on earth). In 1969 he joined Sydney Brenner’s group at the MRC Laboratory of Molecular Biology in Cambridge where he studied the biology and genetics of the nematode worm, Caenorhabditis elegans. He and his team collaborated with Bob Waterston at Washington University in the USA to sequence the genome of this model organism.
In 1992, Sulston was appointed the first Director of the Wellcome Trust Sanger Institute in Cambridgeshire which made the UK’s contribution to the international Human Genome Project. The Institute started with temporary labs and only 15 staff but now has a 600-strong workforce and state-of-the-art buildings. Following publication of the first draft sequence of the human genome in 2000 he was listed among the UK’s 100 most powerful people by the Observer newspaper. Sir John received his knighthood for services to genome research in the 2001 New Year’s Honours. He stepped down as Director in September 2000 but continues to work on C. elegans at the Wellcome Trust Sanger Institute. He is the author with Georgina Ferry of The Common Thread: A Story of Science, Politics, Ethics and the Human Genome.
Academic Education and Appointments:
1963 B.A. University of Cambridge, UK
1966 Ph.D. University of Cambridge, UK
1966-69 Postdoctoral fellow at the Salk Institute for Biological Studies, San Diego, CA
1969 Staff Scientist MRC Laboratory of Molecular Biology
1992-00 Director of the Sanger Centre, Cambridge, UK
Selected Honours and Awards:
1986 Elected to the Royal Society
1986 W. Alden Spencer Award
1991 Gairdner Foundation International Award
1996 Darwin Medal of the Royal Society
1998 Rosenstiel Award
2000 Pfizer Prize for Innovative Science
2000 George W Beadle Medal
2000 Sir Frederick Gowland Hopkins Medal
2001 Knight Bachelor in New Year’s Honours list
2001 The Edinburgh Medal 2001 Prince of Asturias Award (Spain)